S-nitrosylation influences the structure and DNA binding activity of AtMYB30 transcription factor from Arabidopsis thaliana  by Tavares, Carolina Pereira et al.
Biochimica et Biophysica Acta 1844 (2014) 810–817
Contents lists available at ScienceDirect
Biochimica et Biophysica Acta
j ourna l homepage: www.e lsev ie r .com/ locate /bbapapS-nitrosylation inﬂuences the structure and DNA binding activity of
AtMYB30 transcription factor from Arabidopsis thalianaCarolina Pereira Tavares a, Javier Vernal a, Ricardo Alexandre Delena a, Lorenzo Lamattina b,
Raul Cassia b, Hernán Terenzi a,⁎
a Centro de Biologia Molecular Estrutural-INBEB, Departamento de Bioquímica, CCB, Universidade Federal de Santa Catarina, Florianópolis, Brazil
b Instituto de Investigaciones Biológicas, Facultad de Ciencias Exactas y Naturales, Universidad Nacional de Mar del Plata, CC1245 (7600) Mar del Plata, Argentina⁎ Corresponding author.
E-mail addresses: hterenzi@ccb.ufsc.br, hterenzi@me.c
http://dx.doi.org/10.1016/j.bbapap.2014.02.015
1570-9639/© 2014 Elsevier B.V. All rights reserved.a b s t r a c ta r t i c l e i n f oArticle history:
Received 28 September 2013
Received in revised form 14 February 2014
Accepted 19 February 2014
Available online 26 February 2014
Keywords:
MYB transcription factors
Nitric oxide
Nitrosylation
AtMYB30 DBD
Arabidopsis
Biotin switch assayMYB proteins are a family of transcription factors that play an important role in plant development and regula-
tory defense processes. Arabidopsis thalianaMYB30 (AtMYB30), a member of this protein family, is involved in
cell death processes during the hypersensitive response (HR) of plants. HR is characterized by a vast production
of reactive oxygen species (ROS) and nitric oxide (NO). NOmay thus inﬂuence the binding of AtMYB30 toDNA. In
this work we evaluated the effect of NO on AtMYB30 DNA binding activity, and also in the protein structural
properties. A fully active minimal DNA-binding domain (DBD) of AtMYB30 (residues 11–116) containing two
cysteine residues (C49 and C53) was overexpressed and puriﬁed. Site-directed mutagenesis was used to obtain
AtMYB30 DBD mutants C49A and C53A. The DNA binding activity of AtMYB30 DBD, and Cys single mutants is
clearly inhibited upon incubation with a NO donor, and S-nitrosylation was conﬁrmed by the biotin switch
assay. Finally, in order to understand the mechanism of NO effect on AtMYB30 DNA binding activity we per-
formed circular dichroism analysis, to correlate the observed protein function inhibition and a potential structur-
al impairment on AtMYB30 DBD. Indeed, NO modiﬁcation of C49 and C53 residues promotes a subtle
modiﬁcation on the secondary structure of this transcription factor. We thus demonstrated, using various tech-
niques, the in vitro effect of NO on AtMYB30 DBD, and thus the potential consequences of NO activity on plant
metabolism inﬂuenced by this transcription factor.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
MYB transcription factors play a wide variety of physiological func-
tions in the regulation of gene expression in higher plants including
the regulation of primary and secondary metabolism, the control of
cell development and the cell cycle, the participation in defense and re-
sponse to various biotic and abiotic stresses, and hormone synthesis and
signal transduction [1–4]. MYB superfamily members are characterized
by a highly conserved DNA-binding domain – theMYB domain –which
generally comprises up to three imperfect repeats (R1, R2 and R3), each
forming a helix-turn-helix structure of about 50–53 amino acids that in-
tercalates into themajor groove of DNA [1,5]. MYB proteins can be clas-
siﬁed in three subfamilies, according to the number of repetitions in the
adjacent region of MYB domain. R2R3-MYBs (with two repetitions)
constitute the largest MYB subfamily present exclusively in plants,
with 126 members in the model plant Arabidopsis [1,6].
Nitric oxide (NO) is an endogenous signal molecule in plants that
mediates responses to several stimuli through the post-translational
(S-nitrosylation) modiﬁcation of thiol residues in proteins [7].om (H. Terenzi).Regarding transcription factors (TF), Brendeford and coworkers
(1998) reported that NO donors like sodium nitroprusside (SNP) and
S-nitrosoglutathione (GSNO) severely reduced the DNA-binding activi-
ty of c-Myb, a TF found in vertebrates and identiﬁed as the cellular ho-
mologue of v-Myb, an oncogene found in two avian retroviruses that
induce leukemia [8]. A few years ago our group observed a relationship
between the redox state of the R2R3-MYB from Arabidopsis thaliana
AtMYB2 – inﬂuenced by NO donors – and its DNA-binding proper-
ties [9]. Furthermore, S-nitrosylation is gaining increasing importance
as a key regulatory mechanism during plant stress responses, as well
as during changes in the redox potential of the cell [10–12]. The identi-
ﬁcation of the proteome that can be modulated by S-nitrosylation in
plants will certainly contribute to understand the regulation mecha-
nisms and the functional relevance of this process.
The presence of a conserved cysteine residue in theDNA-recognition
helix R2, is a typical characteristic of R2R3-MYB DNA binding domains
in plants. It was demonstrated that NO donors severely inhibited the
DNA-binding activity of c-Myb, and that Cys130 (equivalent to the
Cys53 in R2R3 AtMYB) was responsible for this sensitivity to NO [8].
The reduced state of Cys130 is essential for c-Myb DNA-binding [13].
AtMYB30 is a R2R3-MYB TF which acts as a positive regulator of the
HR, a form of programmed cell death associated with resistance in
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may be regulated by several posttranslationalmodiﬁcations, which acti-
vates or repress its transcriptional activity. An interesting and very re-
cent example of positive interaction is that promoted by BES1, a
component of the brassinosteroid (BR) signaling pathway. It was re-
ported that AtMYB30 interacts with BES1 both in vitro and in vivo, in-
ducing BR downstream target genes [15]. Likewise, sumoylation is
critical for AtMYB30 function during ABA signaling. The SUMO E3 ligase
SIZ1 is required for the sumoylation of AtMYB30 at lysine residue 283,
which is critical for AtMYB30 transcriptional activity in response to
abscisic acid [19].
On the other hand, some AtMYB30 negative regulators were report-
ed. AtMYB30 and the secreted phospholipase AtsPLA2-α physically in-
teract in vivo, as a consequence, AtMYB30 transcriptional activity is
repressed, causing down regulation of plant HR [20]. It was also report-
ed that the helix-loop-helix domain of the Xanthomonas type III effector
xopD interacts with AtMYB30, inhibiting the transcription of MYB30
defense-related target genes, suppressing the Arabidopsis defense [21].
Besides, the Arabidopsis MIEL1 (MYB30-Interacting E3 Ligase1),
ubiquitinates AtMYB30, leading to MYB30 proteasomal degradation
and down regulation of its transcriptional activity [16].
In this work, we demonstrate that S-nitrosylation is a negative regu-
lator of AtMYB30 DNA binding activity in vitro, and that this posttrans-
lational modiﬁcation is able to modify the secondary structure, and the
thermal stability of the protein. This posttranslational modiﬁcation is
coincident with our report about AtMYB2 inhibition by nitrosylation
[9]. Accordingly, a wide array of proteins involved in all major cellular
activities were demonstrated to be negatively regulated by S-
nitrosylation as GAPDH, NADPH oxidase, NPR1, catalase, metacaspase
9, ascorbate peroxidase, rubisco in A. thaliana [22,23].
Thus, the NO-dependent AtMYB30 nitrosylation may provide a
mechanism responsible for the turnoff of the biological activity of this
regulatory protein after the initial response of plants to stress.
2. Material and methods
2.1. AtMYB30 DBD expression and puriﬁcation
The cDNA coding for AtMYB30 was provided by the Arabidopsis Bi-
ological Resource Center (The Ohio State University, Columbus, OH,
USA). This cDNA was used as a template to amplify the entire DNA-
binding domain (DBD) of AtMYB30 by PCR using speciﬁc oligonucleo-
tides. The forward primer contained a NdeI restriction site, AtMYB30
for (5′-GGA AAT CAT ATG GGA GTG AAG AAA GGG CC-3′), and the re-
verse primer contained the stop codon and a XhoI restriction site,
AtMYB30 rev (5′-GTT AAC CTC GAG TTA GAG TTT CTT CTT CAA ATG
AG-3′); the restriction sites are underlined. PCR ampliﬁcation using
Taq DNA polymerase consisted of an initial denaturation step at 95 °C
for 5 min, followed by 30 cycles of denaturation at 95 °C for 45 s, an-
nealing at 60 °C for 30 s, and extension at 72 °C for 1 min, with a ﬁnal
extension step at 72 °C for 10 min in the presence of 1.5 mM MgCl2.
The DNA fragment obtained (345 bp) was digested with NdeI and XhoI
restriction enzymes and ligated into the pET-14b vector (Novagene)
previously digested with the same enzymes. The fragmentwas inserted
downstreamand in-framewith a coding sequence corresponding to the
following amino acid residues carrying a hexahistidine tag:
MGSSHHHHHHSSGLVPRGSHM. The recombinant plasmid was used to
transform Escherichia coli DH5α competent cells. Clones carrying the
pET14b-AtMYB30 recombinant plasmid were identiﬁed by colony PCR
and checked by DNA sequencing. In order to express the recombinant
AtMYB30 DBD, plasmid pET14b-AtMYB30 was used to transform
E. coli BL21(DE3) pLysS. E. coli cells containing the pET14b-AtMYB30 re-
combinant plasmidwere inoculated in 10ml of LB containing ampicillin
(100 μg/ml) and chloramphenicol (50 μg/ml). Overnight cultures were
transferred to 250ml of the samemedium and were incubated at 37 °C
under agitation until an OD value of 0.6 at 600 nm was reached.Isopropyl-β-D-thiogalactopyranoside (IPTG) was added to a ﬁnal con-
centration of 1 mM and cultures were further incubated at 15 °C for
15 h under agitation. Cells were harvested by centrifugation (5000 ×g
for 30 min at 4 °C) and were resuspended in 3 ml of lysis buffer
(50 mM sodium phosphate, pH 8.0) containing 300 mM NaCl, 10 mM
imidazole and a protease inhibitor cocktail (Complete, Mini,
Boehringer-Mannheim). The cells were disrupted by gentle sonication
(6 cycles, 30 s) on ice and centrifuged (10,000 ×g for 30 min at 4 °C).
AtMYB30 DBD was puriﬁed from the supernatant under native condi-
tions by immobilized metal afﬁnity chromatography (IMAC) in a
HisTrap column (GEHealthcare Life Sciences) connected to anÄKTA Pu-
riﬁer 900 system using a linear gradient of imidazole (0–500 mM). The
purity of the protein preparation was assessed by SDS-PAGE in 16% ac-
rylamide slab gels, under reducing conditions (Schägger and Von Jagow,
1987). The gels were stained with Coomassie brilliant blue R-250. The
protein content was determined by the method of Bradford, with bo-
vine serum albumin as standard [24].
2.2. Site-directed mutagenesis
Selected codons in the pET-14bAtMYB30 recombinant plasmidwere
mutated by PCR in order to obtain the following amino acid substitu-
tions in AtMYB30 DBD: C49A, C53A and C49A/C53A. To substitute Cys
49 or Cys 53 to Ala, two rounds of PCRs were performed. In the ﬁrst
round, two halves of the AtMYB30 gene that carried overlapping se-
quences with the intended mutation introduced by each mutagenic
primer were ampliﬁed (AtMYB30 C49A DBD: MUT49for 5′-GGG CTG
CTT AGA GCT AGT AAG AGT-3′ and MUT49rev 5′-ACT CTT ACT AGC
TCT AAG CAG CCC-3′/AtMYB30 C53A DBD: MUT53for 5′-AGT AAG
AGT GCT AGA CTT AGA TGG-3′ and MUT53rev 5′-CCA TCT AAG TCT
AGC ACT CTT ACT-3′/mutations introduced are underlined) [25].
MUT49for or MUT53for were used in association with AtMYB30Rev
and MUT49rev or MUT53rev were used in association with
ATMYB30For. The two mutated fragments obtained were then mixed
and used as template in the second round of PCR in conjunction with
primers AtMYB30For and AtMYB30Rev, under the conditions described
before. The double mutant AtMYB30 C49A/C53A DBD was obtained in
the same way, using AtMYB30 C53A DNA sequence as template. The
DNA fragments obtained were digested with NdeI and XhoI restriction
enzymes and ligated into the pET-14b vector previously digested with
the same enzymes. The recombinant plasmids were used to transform
E. coli DH5a competent cells. The mutations were veriﬁed by DNA se-
quencing. AtMYB30mutant proteinswere expressed andpuriﬁed as de-
scribed for wild type AtMYB30 DBD.
2.3. Electrophoretic mobility shift assay AACAAAC
DNA binding was monitored by electrophoretic mobility shift assay
(EMSA) using the double-stranded oligonucleotide labeled probe (5′-/
Alexa647N/CTTTCTTTACCTACCACCAACCTAACGGTCAAACCAACCAAAC
CTCTC-3′) (MYB binding site with AC typical element is underlined)
[5,15]. All binding reactions were performed in a total volume of 40 μl.
The reaction buffer contained 10 mM Tris–HCl (pH 7.5), 50 mM NaCl,
1mMDTT, 1mMEDTA, 5% glycerol and 0.4 μMof the indicated proteins
(wild type or mutants). Samples treated with the NO donor sodium ni-
troprusside (SNP, 1 mM)were incubated at 4 °C for 15min. After treat-
ment, the oligonucleotide probe (250 nM) was added and the binding
mixture incubated for additional 15 min at 4 °C. The samples were ana-
lyzed by electrophoresis on a 10% native polyacrylamide gel, using a
Tris–borate–EDTA (TBE) buffer system and visualized by ﬂuorescence
in a laser scanner Typhoon FLA9000 (GE Healthcare Life Sciences).
2.4. Biotin switch assay for detection of S-nitrosylated proteins
The protein concentration of the puriﬁed proteins in HEN buffer
(Hepes 25 mM, pH 7.7; EDTA 1 mM) was adjusted to 0.5 mg/ml.
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acetylpenicillamine (SNAP) for 30min at room temperature (RT) in the
dark. After that, proteins were incubated for 30 min (RT) in 300 μl,
25 mM Hepes, pH 7.7 containing 1 mM EDTA; 3.3% (w/v) SDS, 27 mM
MMTS (S-methyl methanethiosulfonate, alkylating reagent for Cys-
SH). Samples were frequently vortexed to facilitate alkylation of non-
nitrosylated, and reduced cysteine residues. A set of samples (control)
was treated with the same volume of DMSO, instead of SNAP. Residual
MMTSwas removed by precipitation with 5 vol of chilled (−20 °C) ac-
etone and the proteins were resuspended in 60 μl HEN buffer supple-
mented with 1% SDS. Biotinylation was achieved by adding 1 mM
ascorbate and 2 mM biotin-HPDP, and incubating at room temperature
for 1 h. To detect biotinylated proteins by western blot, samples from
the biotin switch assay were separated on 10% SDS-PAGE gels, trans-
ferred to PVDF membranes, blocked with non-fat dried milk, and incu-
bated with 1/10,000 mouse anti-biotin antibody (Sigma) for 1 h at
4 °C. Membranes were then washed and incubated for 1 h with anti-
mouse IgG-peroxidase conjugate. Amersham ECL chemiluminescent
kit was used to detect the signals and Typhoon FLA9000 (GE Healthcare
Life Sciences) to visualize the results.2.5. Mass spectrometry
Gel spots of puriﬁed proteins were repeatedly destained in 25 mM
ammonium bicarbonate in 50% acetonitrile. The gel pieces were
dehydrated with 100 μl of acetonitrile and then dried under vacuum
(Concentrator Eppendorf, Hamburg, Germany). After drying, gel frag-
ments were rehydrated on ice in 10 μl of sequencing grade modiﬁed
trypsin (10 μg/ml in 25 mM ammonium bicarbonate (pH 8.0)) or
LyS-C (5 μg/ml in 50 mM HEPES), 10 mM EDTA (pH 8.0) (Promega,
Madison, WI) and incubated for 16 h at 37 °C. The resulting peptides
were extracted with two washing steps (45 μl of 50% acetonitrile in
5% triﬂuoroacetic acid (TFA) for 30 min). Then, the concentrated
peptide extracts were dried in a vacuum system. Extracted peptides
were resuspended in 10 μl 0.1% TFA and a sample of 1 μl of the con-
centrated digest was mixed with 1 μl of a saturated matrix solution
of α-cyano 4-hydroxycinnamic acid (5 mg/ml in 0.1% TFA and 50%
acetonitrile). This mixture was spotted on the MALDI target plate
(Bruker Daltonics, Bremen, Germany) and allowed to crystallize at
RT. MS and MS/MS analysis were performed on a MALDI-TOF/TOF
Autoﬂex III Smartbean mass spectrometer (Bruker Daltonics, Bre-
men, Germany). The MS spectra were acquired in positive ion
mode, using an accelerating voltage of 20 kV and laser frequency of
200 Hz. LIFT mass spectra were acquired in the positive ion mode.
Metastable fragmentation was induced by a nitrogen laserM. musculus QNGTDDWKVIANYLPNRTDVQCQHRW
AtMYB30 --------------------------
AtMYB2 --------------------------
O.sativa PQGEDPLIG-------------IKAA
M. musculus VIAKHL-KGRIGKQCRERWHNHLNPE
AtMYB30 AVPTNTGLLRCSKSCRLRWTNYLRPG
AtMYB2 HIARSSGLKRTGKSCRLRWLNYLRPD
O.sativa FLAKVSGLQRSGKSCRLRWVNYLHPG
* * ** ** * *
M. musculus RWAEIAKLLPGRTDNAIKNHWNSTMR
AtMYB30 RWAAIASYLPQRTDNDIKNYWNTHLK
AtMYB2 RWSKIAQYLPGRTDNEIKNYWRTRVQ
O.sativa RWSRIAKSIPGRTDNEIKNYWRTHLR
** **   * **** *** *
Fig. 1.DNA binding domain sequence alignment of Arabidopsis thalianaAtMYB30 (AF250339_1
mammal (NP_034978.3). Asterisks indicate conserved amino acid residues, and the peptides id
are indicative of the position of the amino acid residue in the complete protein sequence.(337 nm) without acceleration to 6 kV and selected in a timed ion
gate. In the LIFT-cell the fragments were further accelerated to
19 kV. External calibration was performed using peptide standards.
The spectra generated were analyzed with FlexAnalysis 3.3 software
(Bruker Daltonics, Bremen, Germany).
2.6. Puriﬁcation of S-nitrosylated peptides and mass spectrometry
In vitro S-nitrosylation, and subsequent biotinylation of S-
nitrosylated peptides was performed as described above. A neutravidin
pull-down assay was used to purify biotinylated peptides. Brieﬂy, after
biotinylation, biotin-HPDP was removed by acetone precipitation, and
the protein pellet was resuspended in 25 mM Tris HCl buffer and
1 mM EDTA, pH 7.7. Biotin switch-treated samples were digested
using LyS-C endoprotease (Promega, Madison, WI), and incubated for
16 h at 37 °C. After cleavage, a total of 40 μl of neutravidin-agarose
(Thermo Fisher Scientiﬁc) were added and incubated for 1 h at RT.
The matrix was washed ﬁve times with 2 volumes of neutralization
buffer (20 mM HEPES, pH 7.7, 100 mM NaCl, 1 mM EDTA, 600 mM
NaCl and 0.5% Triton X-100) and bound peptides were eluted with neu-
tralization buffer containing 100 mM β-mercaptoethanol. Then, the
eluted peptides were concentrated under vacuum. A sample of 1 μl of
the concentrated and puriﬁed peptideswasmixedwith 1 μl of a saturat-
edmatrix solution ofα-cyano 4-hydroxycinnamic acid, and analyzed by
mass spectrometry as described above.
2.7. Circular dichroism spectroscopy
Wild type AtMYB30 DBD and its mutants (10 μM) were dialyzed
against buffer (10mMHepes, pH 7.4). Spectroscopic analyseswere car-
ried out in a JASCO J-815 spectropolarimeter equipped with a peltier
temperature control unit. Circular dichroism was measured in a 0.2
cmpathlength cuvette (50 nm/min scan speed, response time8 s, band-
width 2 nm, data pitch 0.1 nm/s) with an average of 3 scans for each
spectrum at a wavelength range from 190 nm to 260 nm. Thermal
unfolding was carried out by increasing the temperature of the cuvette
from 4 °C to 70 °C, and monitoring the 222 nmminimum peak. The ef-
fect of S-nitrosylation on protein thermal stability was assayed using
GSNOas aNOdonor, and glutathione as a negative control. The enzymes
were pre-incubated with 1 mM GSNO or GSH for 30 min at 25 °C in
the dark. In order to verify the reversibility of AtMYB30 DBD S-
nitrosylation, the samples were incubated with 1 mM DTT after
GSNO treatment. For all the scans recorded, the baseline spectrum
containing only the buffer or buffer plus nitrosylating agents, and
DTT were subtracted.QKVLNPELIKGPWTKEEDQRVIELVQKYGPKRWS 116
------GVKKGPWTPEEDIILVTYIQEHGPGNWR 38
------DVRKGPWTEEEDAILVNFVSIHGDARWN 46
AAGGGGIMRKGPWTEQEDVQLVWFVRLLGERRWD 82
*****  **  * *
VKKTS------------TEEEDRIIYQAHKRLGN 163
IKRGN-----------FTEHEEKMIVHLQALLGN 87
VRRGN-----------ITLEEQFMILKLHSLWGN 95
LKRGR-----------MSPEEERMVVQLHAKLGN 131
* **
RKVEQEGYLQEPSKASQTPV------A------- 210
KKL------------------------------- 116
KQAK------------------------------ 125
KLKLKQQKQQQSDDHHNDND------DDDDRNSS 185
) withMYB factors from a typical plantmodel (AAU84433.1), AtMYB2 (NP_182241.1), and
entiﬁed inwild type AtMYB30 bymass spectrometry are underlined. Numbers at the right
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In Fig. 1, a primary sequence comparison between DNA binding do-
mains of AtMYB30, AtMYB2, and MYB transcription factors from Oryza
sativa, andMus musculus is depicted, to conﬁrm the similarity observed
in theDNAbinding domain of these transcription factors fromdivergent
species. We also stress the fact that the C49 residue is present only in
AtMYB30, although the C53 is clearly conserved among MYB factors.
Wild type AtMYB30 DBD and cysteine single and double mutants
were expressed in E. coli strain BL21(DE3) pLysS after 15 h induction
with 1mM IPTG at 15 °C. The bacterial lysatewas incubated and treated
as described in Materials and methods. The protein yield was approxi-
mately 4 mg/l of cell culture for wild type and single mutants and
2 mg/l for the double mutant. The protein preparations obtained were
homogeneous as judged by SDS-PAGE, producing a single band with
an apparent molecular mass of 15 kDa (Fig. 2), consistent with the the-
oretical molecular mass (~14,600 Da) predicted for the full-length re-
combinant proteins.
The identity of the puriﬁed wild type AtMYB30 DBD and mutants
was ascertained by MALDI mass spectrometry. The tryptic digest was
consistent with the expected molecular masses of theoretical peptides
and covered 75%, 74%, 53% and 50% of the DBD complete amino acid se-
quence, for wild type, C49A, C53A and C49A/C53A, respectively (data
not shown).
We also checked the intactmass of the proteins to verify the integri-
ty of the recombinant constructs. MALDI mass spectrometry of all re-
combinant proteins was consistent with the theoretical molecular
mass (wild type, 14,647.7 Da; C49A and C53, 14,615.6 Da; and C49/
53A, 14,583.6 Da) predicted for the full-length proteins (Fig. S1). It isFig. 2. Puriﬁcation of recombinant wild type AtMYB30 (DBD) (20 μg) (A), mutant C49A (10 μg)
riﬁcation by afﬁnity chromatography. 1 — Supernatant after sonication; 2 — Flow-through; andimportant to note that we detected the loss of the ﬁrst methionine res-
idue in each full-length protein due to the amino terminal peptidase ac-
tivity, as described [26].3.1. DNA binding activity of wild type AtMYb30, C49A, C53A, and C49A/
C53A DNA binding domains
In order to analyze the DNA binding activity of AtMYB30 DBD and
the potential effect of nitrosylation on cysteine residues we used the
electrophoresis mobility shift assay (EMSA) technique. The AtMYB30
DBD and mutants C49A and C53A retarded the migration of a double-
stranded oligonucleotide containing the binding sequence 5′-ACAA
AAC-3′ (Fig. 3), conﬁrming that the DNA binding module of AtMYB30
(residues 11–116) is sufﬁcient to target and bind DNA. The single site
mutations (C49A or C53A) did not alter the binding activity of
AtMYB30, but the double mutant (C49/53A) was clearly affected in its
function, being unable to interact with DNA. Interestingly, treatment
of wild type AtMYB30 DBD or any of the two single cysteine mutants
with the NO donor sodium nitroprusside (SNP, 1 mM) before the addi-
tion of the speciﬁc DNA probe, completely abolished the formation of a
protein–DNA complex (Fig. 3), other NO donors promote similar effects
(Fig. S4). This effectwas reversed by the addition of 50mMDTT after the
initial NO exposure. These results indicate the reversibility of the NO
modiﬁcation, in accordance with previous reports with similar tran-
scription factors [1,8,9]. In addition, the double mutant C49A/C53A
was unable to interact with the speciﬁc double-stranded oligonucleo-
tide probe indicating that the absence of both cysteine residues abol-
ishes complex formation (Fig. 3).(B), mutant C53A (10 μg) (C) and mutant C49A/C53A (3 μg) (D). SDS-PAGE following pu-
3 — Proteins eluted with imidazole.
Fig. 3.Gelmobility shift assay ofwild type AtMYB30DBD (A), C49A (B), C53A (C) and C49A/C53A (D) using speciﬁc DNA probe. Filled and open arrows indicate protein–DNA complex and
free DNA probe, respectively.
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main, spanning residues 11–116 is functionally active, aswell as the sin-
gle mutant proteins. The binding to DNA is strongly inhibited by
nitrosylating agents, such as SNP, and the inhibition of the DNA-
binding activity forwild type AtMYB30, C49A and C53Amutantswas re-
versed by DTT, indicating that C49 and C53 reduced state is necessary
for DNA-binding activity. These results suggest that DNA-binding activ-
ity of wild type AtMYB30, and its single mutants is probably regulated
by S-nitrosylation, as our group observed for AtMYB2 DBD [9]. These
ﬁndings are also in agreement with the fact that S-nitrosylation is
emerging as a prototypic redox-based post-translational modiﬁcation
regulated by S-nitrosoglutathione (GSNO) reductase, the majorFig. 4. Gel mobility shift assay of wild type AtMYB30 DBD, AtMYB30 C49A, and AtMYB30 C53A
before addition of the DNA probe. Filled and open arrows indicate protein–DNA complex andregulator of total cellular SNO levels in plants [27]. Besides, Yun and co-
workers obtained genetic evidences supporting that the increment in
cysteine thiols modiﬁed by NO facilitates the HR in the absence of the
cell death agonist salicylic acid, a signaling molecule that is produced
in the initial steps after plant–pathogen interaction [12]. Due to the
close proximity of the two cysteines residues in wild type AtMYB30
DBD (C49 and C53)we investigated the existence of a possible disulﬁde
bond between these residues, and whether this bond could affect the
formation of DNA–protein complex. Thus the proteins were incubated
with 5 mM of either reducing agent DTT or GSH before the addition of
DNA probe (Fig. 4). We observed that the DNA–protein complex is
formed even after the treatment of AtMYB30DBDwith reducing agents,using speciﬁc DNA probe. All proteins were previously incubated with DTT or GSH 5 mM
free DNA probe, respectively. SNP, sodium nitroprusside NO donor.
Fig. 6. Circular dichroism spectroscopy in the far-UV spectral region ofwild type AtMYB30
DBD and single Cysmutants. Themeasurementswere donewith 10mMprotein in 10mM
Hepes, pH 7.4. The spectra represent the average of three scans and data represent amean
of three independent experiments.
815C.P. Tavares et al. / Biochimica et Biophysica Acta 1844 (2014) 810–817suggesting that a putative disulﬁde bond between cysteines C49 and
C53 is not required for DNA binding.
3.2. S-Nitrosylation of AtMYB30 as a consequence of NO treatment
Based on the results discussed above we investigated the S-
nitrosylation of wild type AtMYB30 DBD and mutants C49A, C53A, and
C49A/C53A using the biotin switch technique (BST) [28], to fully under-
stand the role of each residue in the NO modiﬁcation.
We observed that wild type AtMYB30 DBD and mutants C49A and
C53A were S-nitrosylated by the NO donor SNAP, when compared
with the negative control (DMSO) (Fig. 5). Similar resultswere obtained
using GSNO and SNP as NO donors (data not shown). This suggests that
both cysteine residues present in the DNA binding domain of AtMYB30
(C49 and C53) are targets for NO mediated S-nitrosylation.
We also detected the nitrosylation of AtMYB30 DBD by mass spec-
trometry (Figs. S2 and S3), the peptide containing C53 residue
(1920 m/z; modiﬁed by iodoacetamide) was sequenced and its identity
conﬁrmed. We thus treated AtMYB30 DBD with a NO donor, and sub-
mitted the sample to the biotin-switch assay. Subsequently the samples
were digested with LysC protease, in order to obtain the C53 containing
peptide, and ﬁnally, the biotinylated peptides were isolated by
neutravidin-agarose chromatography. As shown in Fig. S3, the C53 con-
taining peptidewas enriched after NO donor treatment, thus conﬁrming
its NO modiﬁcation.
3.3. Effect of S-nitrosylation in the secondary structure of wild type
AtMYB30 DBD and mutants C49A and C53A
We used circular dichroism (CD) spectroscopy to analyze the possi-
ble structural modiﬁcation caused by site-directed mutagenesis in the
Cys-mutants (Fig. 6). The CD data obtained for wild type AtMYB30
DBD and single mutants exhibit a typical α-helical secondary structure
proﬁle with minimal peaks at 208 nm and 222 nm. It is possible to ob-
serve that the substitution of Cys49 or Cys53 by alanine did not change
the spectral proﬁle (Fig. 6). Thus, the single mutations do not interfere
directly in the secondary structure of the recombinant proteins.
Besides, in order to evaluate the structural stability of AtMYB30 DBD
upon S-nitrosylation, CD spectra were obtained with wild type
AtMYB30 DBD and Cys-mutants. When the NO donor (GSNO) was
added to wild type AtMYB30 DBD or single mutants, the overall far-
UV spectrum changed (Fig. 7), indicating that S-nitrosylation of each
protein interferes with their secondary structure proﬁle. It is importantFig. 5. S-nitrosylation of AtMYB30 DBD detected by the biotin switch technique. (A) Fifty micro
SNAP (1) or 1 mMDMSO (2) as negative control, separated by SDS-PAGE and stained with Coo
and C49A/C53A. The relative molecular mass of the protein standard is shown on the left.to note that after DTT treatment, the original proﬁle of the proteins
treated with GSNO is partially restored, suggesting the reversibility of
C49 and C53 S-nitrosylation (Fig. 7). It is also possible to assume that
the effect of NO in the CD spectra is more pronounced in the C53A mu-
tant, possibly indicating that modiﬁcation of C49 causes amild structur-
al effect in AtMYB30DBD. From this datawe suggest that, although both
C49 and C53 are potentially S-nitrosylated, C49 seems to be more im-
portant to the structural modiﬁcation of the C53A mutant.
The thermal denaturation of proteins can be monitored by circular
dichroism and it is normally used to determine the stability of a protein.
In this case the thermal denaturation proﬁle of AtMYB30 DBD indicated
a melting temperature (TM) of 38.26 °C while C49A and C53A mutants
were less stable, and a lower melting temperature was observed for
them (32.43 °C and 31.25 °C, respectively) (Fig. 8).
On the other hand, when wild type AtMYB30 DBD was S-
nitrosylated, the thermal denaturation proﬁle indicated a slight increase
of 3.69 ± 1.01 °C in the melting temperature when compared to the
non-nitrosylated enzyme (Fig. 9) and the melting temperature of
C49A also increased in the presence of GSNO (from 33.08 to 39.82;
~6 °C). It is important to note that only for C53A mutant the TM de-
creased in the presence of GSNO (from 29.49 to 23.15), refer to Fig. 9
and Table 1. Oncemore, as indicated above for the effect of nitrosylation
on the overall CD spectra, the S-nitrosylation of the C49 residue (present
in the C53A mutant) promoted the most pronounced effect — thermalgrams of the indicated puriﬁed recombinant proteins were treated separately with 1 mM
massie blue. (B) Detection of S-nitrosylated proteins wild type AtMYB30 DBD, C49A, C53A
Fig. 7. Circular dichroism spectroscopy in the far-UV spectral region ofwild type AtMYB30
DBD (A), C49A (B) and C53A (C) after GSH, GSNO or GSNO andDTT treatment. The spectra
represent the average of three scans and data represent a mean of three independent
experiments. Fig. 9. Boltzmann sigmoidal curve showing unfolding (%) of wild type AtMYB30 DBD (A),
C49A (B) and C53A (C) after GSH or GSNO treatment. Data represent a mean of three in-
dependent experiments.
816 C.P. Tavares et al. / Biochimica et Biophysica Acta 1844 (2014) 810–817sensitivity. The opposing result (higher thermal stability upon
nitrosylation) was detected in wild type and C49A mutant. We then
suggest that residue C49may be responsible for the NO structural mod-
iﬁcations. These results support the evidence that the surrounding envi-
ronment of cysteine residues in proteins affects the reactivity to NO
[29,30].Fig. 8. Boltzmann sigmoidal curve showing unfolding (%) of wild type AtMYB30 DBD,
C49A and C53A. Data represent a mean of three independent experiments.4. Conclusions
Using techniques such as biotin switch, CD, and EMSA we observed
that AtMYB30 Cys49 and Cys53 were nitrosylated by 1 mM SNAP,
inhibiting DNA binding. By site-directed mutagenesis of cysteine resi-
dues it was possible to conﬁrm that the nitrosylation occurs in these
speciﬁc amino acid residues. The DNA–protein interaction was also
strongly inhibited by another nitrosylating agent, such as SNP, and the
inhibition of the DNA-binding activity for wild type and mutants wasTable 1
Average values of TM (°C) ofWT AtMYB30 andmutants after treatmentwith GSH (1mM)
or GSNO (1 mM).
Proteins Melting temperature(TM)
Wild-type AtMYB30 Non-nitrosylated 38.26 °C ± 0.3
Nitrosylated 41.95 °C ± 0.3
AtMYB30 C49A Non-nitrosylated 33.08 °C ± 0.4
Nitrosylated 39.82 °C ± 0.5
AtMYB30 C53A Non-nitrosylated 29.49 °C ± 1.01
Nitrosylated 23.15 °C ± 0.8
817C.P. Tavares et al. / Biochimica et Biophysica Acta 1844 (2014) 810–817reversed by DTT, suggesting that Cys49 and Cys53 are S-nitrosylated
and the reduced state is necessary for DNA-binding activity. Besides,
using circular dichroism we observed that S-nitrosylation affects the
secondary structure of AtMYB30 DBD and mutants C49A and C53A. All
these results suggest that nitrosylation is one of themechanismsdriving
the NO-mediated inhibition of AtMYB30 DBD binding to DNA. Our ﬁnd-
ings underline the importance of this modiﬁcation for AtMYB30 and
support other evidences that S-nitrosylation is an important and wide-
spread regulator of protein function in plant biology. It has been demon-
strated that AtMYB30 is a positive regulator of the hypersensitive
response (HR) which is accompanied by a burst of reactive oxygen
and nitrogen species leading to cell death in plants [16], and that in
non-infected plants, AtMYB30 is ubiquitinated by the E3 ligase MIEL1
triggering its proteasomal degradation and thus, attenuating the HR.
We may speculate that the S-nitrosylation of AtMYB30 and the subse-
quent inhibition of its binding to DNA may be operating during the HR
to limit the damage of an extensive and uncontrolled cell death trig-
gered by a hyperactive AtMYB30. This is the second observation of a
MYB transcription factor in A. thaliana to be inhibited by NO action. In-
deed, it was recently reviewed [31] that growing evidence indicates
AtMYB30 as a multi-regulated protein linked to diverse environmental
stimuli response, acting as amajor regulator of plant responses and sub-
jected tomany different post-translational modiﬁcations (phosphoryla-
tion, sumoylation, ubiquitination). Thiswork brings evidence of a fourth
covalent modiﬁcation in AtMYB30, at least ‘in vitro’.Appendix A. Supplementary data
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbapap.2014.02.015.References
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